Searched for
SRL LTD
RPSG, Inox, Hexa bid for Enel's renewable energy projects in IndiaThe three firms submitted their bids last week in the ₹3,000 crore enterprise value range for Enel's India business comprising renewable en...- Court asks companies to avoid any action that may harm brand SRLOn May 23, Singh had approached the court urging to pass an order restraining SRL diagnostics, SRL and Fortis Healthcare. He also asked the...
- SRL Diagnostics allocates Rs 300-500 cr for expansion by FY23-end"We have allocated Rs 300-500 crore for expansion needs up to FY23-end... Since we already have a strong laboratory network, we will be add...
- Fortis Healthcare approves demerger of diagnostics businessUnder the proposed scheme, SRL, which is engaged in diagnostic business and is a subsidiary of Fortis Healthcare, will be hived off and mer...
- Fortis Healthcare hives off diagnostic business SRL into listed Fortis MalarUnder the proposed scheme, SRL engaged in diagnostic business and is a subsidiary of Fortis Healthcare will be hived off and will be merged...
- Baring Asia, other PEs in talks to buy stake in SRL DiagnosticsThe SRL stake sale had previously attracted interest from a diverse set of buyout and sovereign wealth funds, including Warburg Pincus and ...
- SRL Diagnostics may see exit of PE investors Avigo Capital, Jacob Ballas and IFCPrivate equity investors Avigo Capital, Jacob Ballas and IFC are likely to exit SRL Diagnostics, a subsidiary of hospital chain Fortis Heal...
- SRL in talks with 6 state govts for PPP model diagnostic labsLeading diagnostic chain SRL is in talks with six state governments in the country to start labs at government hospitals.
- Wipro implements solution at SRL DiagnosticsWipro today said it has implemented customer relationship management (CRM) solution at SRL Diagnostics to help transform its customer care ...
- Super Religare Laboratories rechristens itself as 'SRL Diagnostics'; launches new logoDiagnostic Super Religare Laboratories (SRL) has rechristened itself as 'SRL Limited' and created a new brand identity of 'SRL Diagnostics.'
- Super Religare Labs to invest Rs 100 cr to open 25 labs by end of March 2013Super Religare Laboratories (SRL) will invest up to Rs 100 crore to set up 25 laboratories both within and outside the country by the end o...
- Gitanjali Gems fully acquires Giantti Italia SRLGitanjali Gems said it has acquired 10% stake in Giantti Italia SRL from Ambio SRL for undisclosed amount, making the Italian jewellery com...
- Sabre Partners to invest Rs 50 cr in SRL in pre-IPO dealPrivate equity fund Sabre Partners on Wednesday said it will pick up stake worth Rs 50 crore in Super Religare Laboratories (SRL) as a pre-...
- Fortis Healthcare to buy 86% in SRL for 842 crFortis Healthcare (India) Ltd will buy 86% stake in Super Religare Laboratories (SRL) from its promoters at the same value.
- Fortis to pay about Rs 930 cr for 86% stake in SRLFortis Healthcare (India) today said its board has approved acquisition of 86 per cent stake in Super Religare Laboratories (SRL) to be bas...
- Avigo Capital plans to buy 9.27% in SRLAvigo Capital Partners plans to buy 9.27% stake in Super Religare Laboratories (SRL), ahead of the diagnostics chain’s maiden public issue.
- Avigo Capital Partners picks up 9.27 % stake in Super Religare LaboratoriesAvigo has signed a share subscription agreement with SRL under which it will subscribe to 9.27 % of the post investment equity share capita...
- Singh bros may buy Piramal’s 10% in SRL ahead of public issueThe promoters of Super Religare Laboratories Malvinder and Shivinder Singh may buyout Piramal Heathcare’s 10% stake in the country’s larges...
- Piramal Healthcare completes sale of diagnostics arm to SRLPiramal Healthcare on Saturday said it has completed the Rs 600-crore deal to sell its diagnostics arm, PDSPL, to Super Religare Laboratori...
- PEs, banks in talks to buy stake in SRL RanbaxyLeading PE firms and banks such as ICICI Venture, Yes Bank, GM Financial and Standard Chartered are learnt to be in talks with Ranbaxy’s di...
Load More
